244 related articles for article (PubMed ID: 25827072)
21. Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition.
Li S; Zhang J; Yang H; Wu C; Dang X; Liu Y
Sci Rep; 2015 Jul; 5():12410. PubMed ID: 26174737
[TBL] [Abstract][Full Text] [Related]
22. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
[TBL] [Abstract][Full Text] [Related]
23. Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma.
Cao YW; Wan GX; Sun JP; Cui XB; Hu JM; Liang WH; Zheng YQ; Li WQ; Li F
Kaohsiung J Med Sci; 2015 Feb; 31(2):70-6. PubMed ID: 25645984
[TBL] [Abstract][Full Text] [Related]
24. DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail.
Mimoto R; Taira N; Takahashi H; Yamaguchi T; Okabe M; Uchida K; Miki Y; Yoshida K
Cancer Lett; 2013 Oct; 339(2):214-25. PubMed ID: 23791882
[TBL] [Abstract][Full Text] [Related]
25. FBXO31 Suppresses Gastric Cancer EMT by Targeting Snail1 for Proteasomal Degradation.
Zou S; Ma C; Yang F; Xu X; Jia J; Liu Z
Mol Cancer Res; 2018 Feb; 16(2):286-295. PubMed ID: 29117943
[TBL] [Abstract][Full Text] [Related]
26. FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity.
Abida WM; Nikolaev A; Zhao W; Zhang W; Gu W
J Biol Chem; 2007 Jan; 282(3):1797-804. PubMed ID: 17098746
[TBL] [Abstract][Full Text] [Related]
27. FBXL5 inhibits metastasis of gastric cancer through suppressing Snail1.
Wu W; Ding H; Cao J; Zhang W
Cell Physiol Biochem; 2015; 35(5):1764-72. PubMed ID: 25832584
[TBL] [Abstract][Full Text] [Related]
28. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.
Yang C; Chen H; Tan G; Gao W; Cheng L; Jiang X; Yu L; Tan Y
Cancer Lett; 2013 Oct; 340(1):104-12. PubMed ID: 23856032
[TBL] [Abstract][Full Text] [Related]
29. FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression.
Sun R; Xie HY; Qian JX; Huang YN; Yang F; Zhang FL; Shao ZM; Li DQ
Cancer Res; 2018 Sep; 78(18):5274-5286. PubMed ID: 29945959
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
31. CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration.
Abbas T; Mueller AC; Shibata E; Keaton M; Rossi M; Dutta A
Mol Cell; 2013 Mar; 49(6):1147-58. PubMed ID: 23478445
[TBL] [Abstract][Full Text] [Related]
32. Regulation of TGF-β signaling, exit from the cell cycle, and cellular migration through cullin cross-regulation: SCF-FBXO11 turns off CRL4-Cdt2.
Abbas T; Keaton M; Dutta A
Cell Cycle; 2013 Jul; 12(14):2175-82. PubMed ID: 23892434
[TBL] [Abstract][Full Text] [Related]
33. XBP1 induces snail expression to promote epithelial- to-mesenchymal transition and invasion of breast cancer cells.
Li H; Chen X; Gao Y; Wu J; Zeng F; Song F
Cell Signal; 2015 Jan; 27(1):82-9. PubMed ID: 25280941
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the CRL4(Cdt2) ubiquitin ligase and cell-cycle exit by the SCF(Fbxo11) ubiquitin ligase.
Rossi M; Duan S; Jeong YT; Horn M; Saraf A; Florens L; Washburn MP; Antebi A; Pagano M
Mol Cell; 2013 Mar; 49(6):1159-66. PubMed ID: 23478441
[TBL] [Abstract][Full Text] [Related]
35. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
Jin L; Chen J; Li L; Li C; Chen C; Li S
Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
[TBL] [Abstract][Full Text] [Related]
36. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
[TBL] [Abstract][Full Text] [Related]
37. Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition.
Li X; Kong X; Huo Q; Guo H; Yan S; Yuan C; Moran MS; Shao C; Yang Q
Cancer Sci; 2011 Jun; 102(6):1151-7. PubMed ID: 21371176
[TBL] [Abstract][Full Text] [Related]
38. Epithelial to mesenchymal transition is associated with rapamycin resistance.
Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
[TBL] [Abstract][Full Text] [Related]
39. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer.
Li H; Wang Z; Zhang W; Qian K; Xu W; Zhang S
Cancer Lett; 2016 Jan; 370(1):39-55. PubMed ID: 26458995
[TBL] [Abstract][Full Text] [Related]
40. N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling.
Kim MJ; Lim J; Yang Y; Lee MS; Lim JS
Cancer Lett; 2014 Nov; 354(1):33-42. PubMed ID: 25153349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]